These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 3495583)

  • 21. Age-dependent changes in B lymphocyte lineage cell populations of autoimmune-prone BXSB mice.
    Jyonouchi H; Kincade PW; Good RA
    J Immunol; 1985 Feb; 134(2):858-64. PubMed ID: 2856930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgene-mediated hyper-expression of IL-5 inhibits autoimmune disease but increases the risk of B cell chronic lymphocytic leukemia in a model of murine lupus.
    Wen X; Zhang D; Kikuchi Y; Jiang Y; Nakamura K; Xiu Y; Tsurui H; Takahashi K; Abe M; Ohtsuji M; Nishimura H; Takatsu K; Shirai T; Hirose S
    Eur J Immunol; 2004 Oct; 34(10):2740-9. PubMed ID: 15368290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice.
    Verthelyi D; Ansar Ahmed S
    J Autoimmun; 1997 Apr; 10(2):115-25. PubMed ID: 9185873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute SLE in F1 hybrids between SB/Le and NZW mice; prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice.
    Izui S; Masuda K; Yoshida H
    J Immunol; 1984 Feb; 132(2):701-4. PubMed ID: 6690614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CBA/N X-linked defect delays expression of the Y-linked accelerated autoimmune disease in BXSB mice.
    Golding B; Golding H; Foiles PG; Morton JI
    J Immunol; 1983 Mar; 130(3):1043-6. PubMed ID: 6600468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygosity of the major histocompatibility complex controls the autoimmune disease in (NZW x BXSB) F1 mice.
    Kawano H; Abe M; Zhang D; Saikawa T; Fujimori M; Hirose S; Shirai T
    Clin Immunol Immunopathol; 1992 Dec; 65(3):308-14. PubMed ID: 1451334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of consomic mice bearing the Y chromosome of the BXSB mouse.
    Hudgins CC; Steinberg RT; Klinman DM; Reeves MJ; Steinberg AD
    J Immunol; 1985 Jun; 134(6):3849-54. PubMed ID: 3989299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anxiety behavior, exploratory behavior, and activity in NZB x NZW F1 hybrid mice: role of genotype and autoimmune disease progression.
    Schrott LM; Crnic LS
    Brain Behav Immun; 1996 Sep; 10(3):260-74. PubMed ID: 8954598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial and motor abilities during the course of autoimmune disease in (NZW x BXSB)F1 lupus-prone mice.
    Arabo A; Costa O; Tron F; Caston J
    Behav Brain Res; 2005 Nov; 165(1):126-37. PubMed ID: 16168499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analyses of thymic abnormalities in autoimmune-prone (NZW x BXSB) F1 mice.
    Adachi Y; Inaba M; Inaba K; Than S; Kobayashi Y; Ikehara S
    Immunobiology; 1993 Aug; 188(4-5):340-54. PubMed ID: 8244442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the deletion within T cell receptor beta-chain gene of NZW mice contribute to autoimmunity in (NZB X NZW)F1 mice?
    Yanagi Y; Hirose S; Nagasawa R; Shirai T; Mak TW; Tada T
    Eur J Immunol; 1986 Sep; 16(9):1179-82. PubMed ID: 3758154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. H-2-linked control of the Yaa gene-induced acceleration of lupus-like autoimmune disease in BXSB mice.
    Merino R; Fossati L; Lacour M; Lemoine R; Higaki M; Izui S
    Eur J Immunol; 1992 Feb; 22(2):295-9. PubMed ID: 1537372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of anti-CD154 treatment on B cells in murine systemic lupus erythematosus.
    Wang X; Huang W; Schiffer LE; Mihara M; Akkerman A; Hiromatsu K; Davidson A
    Arthritis Rheum; 2003 Feb; 48(2):495-506. PubMed ID: 12571860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological abnormalities in BXSB mice at the onset of SLE development.
    Morrison LJ; Menzies CB; Behan WM; Behan PO
    J Clin Lab Immunol; 1990 May; 32(1):5-11. PubMed ID: 1967037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural characterization of an (NZB x NZW)F1 mouse-derived IgM monoclonal antibody that binds through V region-dependent interactions to murine IgG anti-DNA antibodies.
    Margaritte C; Gilbert D; Brard F; Tron F
    J Autoimmun; 1994 Dec; 7(6):711-25. PubMed ID: 7888030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between anti-nucleophosmin and anti-cardiolipin antibodies in (NZW x BXSB)F1 mice and human systemic lupus erythematosus.
    Lartigue A; Drouot L; Jouen F; Charlionet R; Tron F; Gilbert D
    Arthritis Res Ther; 2005; 7(6):R1394-403. PubMed ID: 16277692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.